MedPath

A study to compare the effect of Dexmedetomidine and Lignocaine in preventing Etomidate-induced Myoclonus

Not Applicable
Conditions
Health Condition 1: 4- Measurement and Monitoring
Registration Number
CTRI/2021/06/034499
Lead Sponsor
Shammy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade I and II

Patients willing to participate

Exclusion Criteria

1. Bradycardia

2. Upper respiratory tract infection 2 weeks before surgery

3. History of allergy to study drugs (Dexmedetomidine, Lignocaine, Etomidate)

4. Diabetes Mellitus, Hypertension, Cardiovascular, Respiratory and Neurologic disease

5. Adrenocortical dysfunction

6. Morbid obesity

7. Emergency surgery patients

8. Received sedatives, analgesics or opioids within 24 hours prior to surgery

9. Communication problems

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath